We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?

As the COVID-19 pandemic continues to escalate in the United States, concerns have been raised that persons of lower socioeconomic status, especially in urban environments, may be at greater risk of complications. Getting medications to this group, however, highlights additional disparities that must be addressed for there to be meaningful chance that these medications can help this at-risk population.